ConductScience.org, home

Paper42904151PubMed

Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review.

Omidi Sarajar B and 4 others. Cancer Manag Res, 2026.

Cite this record

ConductScience Library. Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review. Papers, record 42904151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42904151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review.
Journal
Cancer Manag Res
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-22

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omidi Sarajar BBehnam
2Khederzadeh AAram
3Payoon AAsghar
4Zarei MHMohammad Hadi
5Jafarzadeh EEmadhttps://orcid.org/0000-0002-2172-3764

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130944622Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway.Oncol Lett2019https://conductscience.org/library/papers/30944622PubMed
222540333Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.J Obstet Gynaecol Res2012https://conductscience.org/library/papers/22540333PubMed
334707776Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.Oxid Med Cell Longev2021https://conductscience.org/library/papers/34707776PubMed
421415163Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.Cancer Res2011https://conductscience.org/library/papers/21415163PubMed
541528114Cancer statistics, 2026.CA Cancer J Clin2026https://conductscience.org/library/papers/41528114PubMed
640906543Synergistic Enhancement of Cisplatin Anticancer Efficacy by Photobiomodulation Therapy: A Systematic Review.Photobiomodul Photomed Laser Surg2025https://conductscience.org/library/papers/40906543PubMed
740387464Targeting Cancer Stem Cells and Hedgehog Pathway: Enhancing Cisplatin Efficacy in Ovarian Cancer With Metformin.J Cell Mol Med2025https://conductscience.org/library/papers/40387464PubMed
835339109Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer.Biomed Pharmacother2022https://conductscience.org/library/papers/35339109PubMed
931032880Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.Br J Pharmacol2019https://conductscience.org/library/papers/31032880PubMed
1033809479Strategies for Cancer Treatment Based on Photonic Nanomedicine.Materials (Basel)2021https://conductscience.org/library/papers/33809479PubMed
1133319669Resistance to Intervention: Paclitaxel in Breast Cancer.Mini Rev Med Chem2021https://conductscience.org/library/papers/33319669PubMed
1227118574Combinational strategies of metformin and chemotherapy in cancers.Cancer Chemother Pharmacol2016https://conductscience.org/library/papers/27118574PubMed
1323228696
Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.
Biochem Pharmacol2013https://conductscience.org/library/papers/23228696PubMed
1424096736Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells.Mol Cell Biochem2014https://conductscience.org/library/papers/24096736PubMed
1529869309Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy.AAPS PharmSciTech2018https://conductscience.org/library/papers/29869309PubMed
1639225830Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39225830PubMed
1723707609Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.Toxicol Appl Pharmacol2013https://conductscience.org/library/papers/23707609PubMed
1831029218Paclitaxel.Profiles Drug Subst Excip Relat Methodol2019https://conductscience.org/library/papers/31029218PubMed
1940505600The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis.Transl Oncol2025https://conductscience.org/library/papers/40505600PubMed
2037893061Regulation of Protein-Induced Apoptosis and Autophagy in Human Hepatocytes Treated with Metformin and Paclitaxel In Silico and In Vitro.Biomedicines2023https://conductscience.org/library/papers/37893061PubMed

See all 51 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42904151

GET https://conductscience.org/api/papers/v1/42904151/references?page=2